Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Protein-protein Interfaces

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

Protein Networks

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

GATSBI: Improving context-aware protein embeddings through biologically motivated data splits.

bioRxiv : the preprint server for biology·2026

Same author

Publisher Correction: CRISPR-GPT for agentic automation of gene-editing experiments.

Nature biomedical engineering·2025

Same author

SubCell: Proteome-aware vision foundation models for microscopy capture single-cell biology.

bioRxiv : the preprint server for biology·2025

Same author

Empirical Drug Dosage Validates Pharmacogenomic Associations in All of Us.

Clinical and translational science·2025

Same author

Reframing Justice in Healthcare AI: An Ubuntu-Based Approach for Africa.

Developing world bioethics·2025

Same author

Toward a framework for risk mitigation of potential misuse of artificial intelligence in biomedical research.

Nature machine intelligence·2025

Same journal

Complex Indel Detection: A Simulation-Based Framework and Parsing with FreeBayes.

bioRxiv : the preprint server for biology·2026

Same journal

Emulating the gingival-tooth interface during bacterial, fungal, and viral infection in a microphysiological model of the human oral cavity.

bioRxiv : the preprint server for biology·2026

Same journal

Local SNP-explained methylation variation reveals genetically anchored and exposure-associated methylation architecture in the human brain.

bioRxiv : the preprint server for biology·2026

Same journal

Perinatal Semaglutide Treatment Improves Maternal Health and Mitigates Offspring Metabolic Dysfunction in a Mouse Model of Maternal Obesity.

bioRxiv : the preprint server for biology·2026

Same journal

Pervasive cryptic selection in the human noncoding genome.

bioRxiv : the preprint server for biology·2026

Same journal

Secreted ORF8 reprograms macrophages to enhance SARS-CoV-2 infection of lung epithelial cells.

bioRxiv : the preprint server for biology·2026

See all related articles

Search research articles

Home
Drug-target Interaction Prediction With Piglet.

Home
Drug-target Interaction Prediction With Piglet.

Related Experiment Video

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

Drug-Target Interaction Prediction with PIGLET.

Kristy A Carpenter¹, Russ B Altman²

¹Department of Biomedical Data Science, Stanford University, Stanford, California, USA.

Biorxiv : the Preprint Server for Biology

|February 27, 2026

View abstract on PubMed

Summary

This summary is machine-generated.

A new graph transformer method, PIGLET, improves drug-target interaction prediction by using a knowledge graph. This approach shows superior performance on a rigorous drug-based split, advancing computational drug discovery.

Keywords:

Computational Biology Drug Discovery Drug-Target Interaction Graph Neural Network Knowledge Graph

More Related Videos

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity AIDN: A Translational Neuroscience Approach

Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity AIDN: A Translational Neuroscience Approach

Published on: June 11, 2017

Related Experiment Videos

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity AIDN: A Translational Neuroscience Approach

Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity AIDN: A Translational Neuroscience Approach

Published on: June 11, 2017

Area of Science:

Computational biology
Drug discovery
Bioinformatics

Background:

Drug-target interaction (DTI) prediction is crucial for computational drug development.
Current deep learning models for DTI prediction, while high-performing, have limited real-world impact.
Existing methods often rely on simplified drug and target representations.

Purpose of the Study:

To introduce a novel graph transformer method for DTI prediction.
To leverage a comprehensive proteome-wide knowledge graph for enhanced prediction accuracy.
To address the limitations of existing DTI prediction models in accelerating drug discovery.

Main Methods:

Developed PIGLET, a graph transformer model for DTI prediction.
Utilized a knowledge graph incorporating binding pocket similarity, protein-protein interactions, and drug similarity.

Benchmarked PIGLET against existing models on the Human dataset using random and drug-based splits.

Main Results:

PIGLET demonstrated superior performance compared to existing models on a rigorous drug-based split.
All models performed similarly on the traditional random split.
The study highlights PIGLET's utility through a real-world drug discovery case study.

Conclusions:

PIGLET offers a more robust and accurate approach to DTI prediction.
The knowledge graph-based method enhances the reliability of predictions for real-world applications.
This advancement has the potential to significantly accelerate computational drug discovery efforts.